Skip to main content
Year archive

Biotest AG — 2020 filings

All 46 regulatory filings released by Biotest AG (BIO3) in 2020, sourced directly from the official regulator.

46 Filings
2020 Period
2020 filings (46)
Filing Released Lang
Biotest AG: Biotests Pentaglobin(R) is a treatment option for COVID-19 patients additionally affected by bacterial infections
Regulatory Filings
2020-11-26 English
Biotest AG: Biotest increases adjusted 9-month EBIT by over 21% to 52 million
Earnings Release 9M 2020
2020-11-12 English
Investor Presentation 2020
Investor Presentation
2020-11-12 German
Investor Presentation 2020
Investor Presentation
2020-11-12 English
Q3 statement / Q3 financial report 2020
Interim / Quarterly Report 9M 2020
2020-11-12 German
Biotest AG: Biotest treats first COVID-19 patient with trimodulin
Regulatory Filings
2020-10-06 English
Biotest AG:
M&A Activity
2020-10-04 English
Biotest AG: Biotest is one of the first plasma protein manufacturers to provide digital package leaflets for all products
Environmental & Social Information
2020-09-10 English
Biotest AG: Biotest phase II study for the treatment of severe COVID-19 patients with trimodulin approved
Regulatory Filings
2020-09-03 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
Environmental & Social Information
2020-09-03 German
Biotest AG: Biotest achieves another important clinical milestone for IgG Next Generation
Regulatory Filings
2020-09-01 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
Audit Report / Information FY 2019
2020-08-28 German
Biotest AG: Biotest increases sales in the first half of 2020 by over 20% to 234.8 million
Earnings Release H1 2020
2020-08-13 English
Datum:13.08.2020
Interim / Quarterly Report H1 2020
2020-08-13 German
Investor Presentation 2020
Investor Presentation
2020-08-13 German
Investor Presentation 2020
Investor Presentation
2020-08-13 English
Half-yearly financial report 2020
Interim / Quarterly Report H2 2020
2020-08-13 English
Halbjahresfinanzbericht 2020
Interim / Quarterly Report H2 2020
2020-08-13 German
Datum:03.08.2020
AGM Information
2020-08-03 German
Biotest AG: Biotest presented promising data on next generation recombinant Factor VIII at ISTH 2020
Regulatory Filings
2020-07-21 English
Biotest AG: Biotest Supervisory Board extends contracts with the Board of Management
Board/Management Information
2020-07-20 English
Biotest AG: Biotest submits phase II study with trimodulin for the treatment of severe COVID-19 patients
Regulatory Filings
2020-07-16 English
Report Publication Announcement 2020
Report Publication Announcement
2020-07-09 English
Report Publication Announcement 2020
Report Publication Announcement
2020-07-09 English
Hinweis auf Jahresfinanzbericht vom 01.01.2019 bis zum 31.12.2019
Report Publication Announcement
2020-07-09 German
Datum:09.07.2020
Report Publication Announcement
2020-07-09 German
Datum:03.07.2020
Audit Report / Information FY 2019
2020-07-03 German
Konzernabschluss zum Geschäftsjahr vom 01.01.2018 bis zum 31.12.2018
Audit Report / Information FY 2018
2020-06-16 German
Biotest AG: Biotest successfully enters China, the world's biggest Human Albumin market
M&A Activity
2020-06-10 English
Biotest AG: Biotest's Zutectra(R) demonstrates improved quality of life in a study with liver transplant patients
Regulatory Filings
2020-06-08 English
Biotest AG: Biotest achieves significant milestone by completing phase I/III clinical trial with fibrinogen
Legal Proceedings Report
2020-05-26 English
Datum:14.05.2020
Audit Report / Information FY 2019
2020-05-14 German
Biotest AG: Annual General Meeting approves dividend distribution
AGM Information
2020-05-08 English
Biotest AG: Biotest increases sales by 26%
Earnings Release Q1 2020
2020-05-08 English
Q1 statement / Q1 financial report 2020
Interim / Quarterly Report Q1 2020
2020-05-08 German
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 08.05.2020 in Dreieich mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2020-04-08 German
Biotest AG: Biotest produces life-saving medicine derived from plasma from healed COVID-19 patients and participates in a cross-industry initiative
Environmental & Social Information
2020-04-06 English
Biotest AG: Biotest is developing with Trimodulin a COVID-19 therapy for patients with a severe course of the disease
Regulatory Filings
2020-04-03 English
AGM Information 2020
AGM Information
2020-04-01 English
Earnings Release 2019
Earnings Release FY 2019
2020-04-01 English
Biotest AG: Biotest exceeds EBIT forecast in the 2019 financial year
Earnings Release FY 2019
2020-03-30 English
Annual financial report 2019
Annual Report FY 2019
2020-03-30 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-03-02 English
Biotest AG: Biotest exceeds already raised EBIT guidance
Earnings Release FY 2019
2020-02-26 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-25 English
Biotest AG: Biotest's CMV-specific hyperimmunoglobulin Cytotect CP Biotest receives UK marketing authorisation
Regulatory Filings
2020-01-15 English